by Collidge, T.A. et al.
- Text changed:
[Stub message]*** Disease relevance of
Thirteen (93%) of 14 patients withGADOLINIUM***nephrogenic systemic fibrosishad undergonegadolinium-enhanced MR imaging compared with 408 (22.5%) of 1812 nonaffected patients (P<.001)[Ref].